Although current chemotherapy regimens are effective at eliminating the bulk of acute myeloid leukemia (AML) blasts, the disease relapses in the majority of patients. 1 Whether relapse arises through ...
iCare 1: A prospective clinical trial to predict treatment response based on genomics-informed computational biology in patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback